Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.
Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe.
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection.
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Macrophage CD5L is a target for cancer immunotherapy.
Syphilis vaccine: challenges, controversies and opportunities.
The first year of young group of the Spanish immunology society: Progress, challenges, and next steps.